Detalles de la búsqueda
1.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
2.
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
Clin Infect Dis
; 76(3): e702-e709, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789253
3.
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning.
BMC Med Res Methodol
; 22(1): 223, 2022 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35962372
4.
Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018).
Sex Transm Infect
; 97(4): 290-296, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703845
5.
Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea.
Clin Infect Dis
; 64(12): 1788-1790, 2017 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329169
6.
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.
Vaccine
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839521
7.
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
Int J Drug Policy
; 114: 103981, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36893502
8.
Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.
Int J Drug Policy
; 116: 104026, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075626
9.
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Int J Drug Policy
; 103: 103627, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218989
10.
Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study.
J Int AIDS Soc
; 25(9): e25994, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050916
11.
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
Int J Drug Policy
; 96: 103343, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215459
12.
National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the 'first 90' from program and survey data.
AIDS
; 33 Suppl 3: S255-S269, 2019 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31764066
13.
Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?
Can Liver J
; 5(4): 441-444, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38144406
14.
Striving toward hepatitis C elimination in the era of COVID-19.
Can Liver J
; 4(1): 4-7, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35991473
15.
Evaluation of Testing Frequency and Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance Strategies in Long-Term Care Facilities.
J Am Med Dir Assoc
; 21(11): 1574-1576.e2, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32994117
16.
National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the 'first 90' from program and survey data
AIDS (Lond.)
; 33(3): 225-269, dez 15, 2019. tab, ilus, graf
Artículo
en Inglés
| AIM, RSDM | ID: biblio-1532592
Resultados
1 -
16
de 16
1
Próxima >
>>